The use of human stromal vascular fraction(SVF) and platelet-rich plasma(PRP) in treatment of therapy-resistant diabetic foot ulcers: a randomized control trial phase III

Mashhad University of Medical Sciences0 个研究点目标入组 20 人开始时间: 待定最近更新: 2023年10月16日

试验速览

暂无简介。

•Having a diabetic ulcer grade 1 to 4 according to Wagner's classification
•Having a single wound in the legs and extremities (fingers, soles, heels, on the toes) that has been at least 4 weeks old
•No smoking, alcohol and drug addiction
•Not taking drugs that may interfere with wound healing, such as corticosteroids, immunosuppressive agents, and cytotoxic agents
•Not having concurrent diseases such as cancers, vasculitis, kidney and liver failure, and heart failure that may cause problems in wound healing
•Informed consent of patients

•Patients with acute bone inflammation or osteomyelitis
•A wound with visible bone in the target area of treatment
•Infected diabetic foot ulcers
•Charcot deformity
•History of treatment with chemotherapy drugs or radiation therapy in 3 months before the start of treatment
•Hemoglobin less than 10mg/dL
•History of treatment with growth factors during two weeks before starting treatment
•Patients with less than 100,000 platelets
•Vascular problems should not be observed in the wound (not ABI?0.7)

发起方